NASDAQ: GNTA - Genenta Science S.p.A.

Yield per half year: -35.95%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Genenta Science S.p.A.

Extended chart Simple chart
Financial Markets by TradingView

About Genenta Science S.p.A.

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma.

more details
In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-12-15
ISIN US36870W1009
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета eur
Сайт https://www.genenta.com
Цена ао 4.13
Change price per day: -1.13% (3.79)
Change price per week: +5.19% (3.562)
Change price per month: -2.17% (3.83)
Change price per 3 month: -11.57% (4.2371)
Change price per half year: -35.95% (5.85)
Change price per year: +24.9% (3)
Change price per 3 year: -43.65% (6.65)
Change price per year to date: -30.09% (5.36)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 4.11 4
P/E 0 0
EV/EBITDA -7.02 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -51 0
ROE, % -55.78 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 154.8 10
Yield EPS, % 575.04 10
Total: 8
More

Institutions Volume Share, %
Bank Julius Baer & Co. Ltd, Zurich 412547 2.26
Algebris (UK) LTD 45000 0.25
UBS Group AG 2301 0.01
Morgan Stanley 500 0



Head Job title Payment Year of birth
Dr. Luigi Naldini M.D., Ph.D. Co-Founder & Chairman of the Executive Scientific Board N/A 1959 (66 years)
Dr. Bernard Rudolph Gentner M.D., Ph.D. Co-Founder & Member of the Executive Scientific Board N/A 1975 (50 years)
Mr. Richard B. Slansky Chief Financial Officer N/A 1958 (67 years)
Dr. Carlo Russo M.D. Chief Medical Officer & Head of Development N/A 1953 (72 years)
Dr. Stefania Mazzoleni Ph.D. Director of Program Development N/A 1982 (43 years)
Ms. Barbara Regonini Director of Finance N/A 1973 (52 years)
Mr. Pierluigi Paracchi Co-Founder, Chairman & CEO 1973 (52 years)

Address: Italy, Milan, Via Olgettina No. 58 - open in Google maps, open in Yandex maps
Website: https://www.genenta.com